Parents of new babies should be considered for a whooping cough booster, say experts

Nov 28, 2008

A booster vaccination for parents of new babies and other household members may be the most effective way of preventing the fatal form of whooping cough in young infants, say a group of paediatric intensive care doctors on bmj.com today.

Whooping cough (pertussis) is a distressing infectious disease which affects infants and young children. Vaccination is effective and is usually given to infants at two to four months of age, with a further booster after three years. But evidence is growing that the incidence of pertussis is rising in adolescents and adults.

Infectious adults within a family are the main source of infection for unimmunised infants.

Doctors at the Royal Hospital for Sick Children in Edinburgh report two fatal cases of invasive pertussis in unvaccinated young infants.

In the first case, a one-month old boy presented to hospital with a five-day history of cough, runny nose and difficulty feeding. Both parents, and an elder sibling, reported coughing spells with vomiting in the previous two weeks.

The sibling was fully vaccinated. There was no record of the parents' childhood vaccination status but the mother received a pertussis booster in 1986.

The child was transferred to intensive care, but despite maximum therapy, died within 24 hours.

In the second case, a six-week old girl presented to hospital with a five-day history of cough and breathlessness. Her mother had a persistent cough for more than two weeks. The mother had received all her childhood immunisations including pertussis, there was no record of the father's pertussis immunisation status.

The child died within 30 hours despite maximum therapy. The patient's mother subsequently tested positive for pertussis infection.

This report demonstrates the devastating course of invasive pertussis in young infants, say the authors.

Pre-vaccination infants now account for the majority of pertussis-related complications, hospitalisations and deaths and most infants catch the disease from affected household members, with parents accounting for more than half of the cases.

As a result, several countries, including the USA and Australia, have introduced booster doses for adolescents and adults. France and Germany also recommend a targeted booster for parents and healthcare workers in contact with young children.

Mortality remains high for young infants developing invasive pertussis despite modern paediatric intensive care, say the authors. The best solution is to prevent infection. The introduction of an adult booster or more targeted vaccination of household contacts of young infants should be considered, they conclude.

Source: British Medical Journal

Explore further: Flu season, early again, hitting hard in South and Midwest

add to favorites email to friend print save as pdf

Related Stories

Whooping cough at epidemic levels in California

Jun 24, 2010

Whooping cough is now at epidemic levels in California and the state could record the highest number of illnesses and death due to the disease in 50 years, the state's top health official said Wednesday.

Whooping cough vaccine may be losing its punch: study

Feb 10, 2010

(PhysOrg.com) -- Vaccination programs against whooping cough may not be fully effective because the bacteria that cause the disease have evolved new strains, a new study has found. A team of Australian scientists has ...

Recommended for you

Evidence-based recs issued for systemic care in psoriasis

6 hours ago

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

6 hours ago

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

6 hours ago

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

Discovery of genes that predispose a severe form of COPD

9 hours ago

A study by Ramcés Falfán-Valencia, researcher at the National Institute of Respiratory Diseases (INER), found that the mestizo Mexican population has a number of variations in certain genes that predispose ...

On the environmental trail of food pathogens

10 hours ago

Tracking one of the deadliest food contamination organisms through produce farms and natural environments alike, Cornell microbiologists are showing how to use big datasets to predict where the next outbreak could start.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.